| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $3,650,360 ) |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01DK134053 | Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | 000 | 4 | NIH | 1/14/2026 | $430,127 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01HL178459 | Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation | 001 | 2 | NIH | 3/25/2026 | $17,384 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01HL178459 | Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation | 000 | 2 | NIH | 3/5/2026 | $550,490 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01HD104418 | Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | 001 | 5 | NIH | 3/30/2026 | $53,314 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01HD104418 | Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | 000 | 5 | NIH | 1/16/2026 | $479,823 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01ES036248 | Developmental pyrethroid exposure in the prairie vole as a model of environmental risk for autism | 000 | 2 | NIH | 2/5/2026 | $592,124 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R21CA292033 | Novel selective allosteric modulators of PTHrP/PTH receptor to inhibit prostate cancer metastases | 000 | 1 | NIH | 4/28/2026 | $418,822 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01CA272760 | Enhancing chemotherapeutic efficacy in triple-negative breast cancer via DSTYK silence | 000 | 4 | NIH | 3/27/2026 | $374,135 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01CA288278 | Molecular basis and targeting of FASN in expanding PARPi utility for TNBC | 001 | 2 | NIH | 4/17/2026 | $52,512 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01CA288278 | Molecular basis and targeting of FASN in expanding PARPi utility for TNBC | 000 | 2 | NIH | 2/10/2026 | $472,607 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R00DA055064 | Investigating the long-term effects of prenatal circadian rhythm disruption on substance use-related disorders | 000 | 4 | NIH | 2/9/2026 | $247,843 |
| | 2026 | 2026 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 00 | 25 | HRSA | 3/25/2026 | $86,666 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 02 | 19 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R56MH139698 | Serotonin-mediated reorganization of the adolescent medial prefrontal cortex | 000 | 1 | NIH | 4/9/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01NS122534 | Pre and post-synaptic pathways underlying the stress response in the adrenal medulla | 000 | 10 | NIH | 3/5/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01AG071332 | PPARG regulates osteocyte bioenergetics and function during aging | 000 | 5 | NIH | 3/17/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 02 | 15 | HRSA | 1/5/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 04 | 24 | HRSA | 1/16/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 03 | 24 | HRSA | 12/11/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 02 | 19 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R21DA055558 | Zebrafish Screens to Identify Agents which Reverse the Effects of Synthetic Opioids | 000 | 2 | NIH | 2/11/2026 | -$2,503 |
| | 2026 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R21CA277252 | Targeting FASN to eliminate metastatic breast cancer in the brain | 000 | 2 | NIH | 12/3/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R03AG080418 | Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease | 000 | 2 | NIH | 3/31/2026 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 000 | 6 | NIH | 3/26/2026 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 02 | 19 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R21MH125277 | A large sample machine learning network analysis of vertex cortical thickness measures for high resolution definition of PTSD related cortical structure abnormalities | 000 | 2 | NIH | 4/28/2026 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01GM127656 | Effective targeting survivin dimerization interface with small molecule inhibitors | 000 | 5 | NIH | 1/16/2026 | $0 |
| | 2026 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 02 | 19 | CDC | 11/13/2025 | $0 |
| | 2026 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01HL148585 | Mechanical Control of Coronary Angiogenesis in Myocardial Adaptation to Ischemia | 000 | 4 | NIH | 2/18/2026 | $0 |
| | 2026 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | CE146595 | Community Project Funding/Congressionally Directed Spending - Construction | 06 | 1 | HRSA | 1/14/2026 | -$122,985 |
| | 2026 | 2021 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-3390 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 02 | 19 | CDC | 11/13/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $14,303,677 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA272760 | Enhancing chemotherapeutic efficacy in triple-negative breast cancer via DSTYK silence | 001 | 3 | NIH | 3/25/2025 | $217,702 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK133203 | Role of GSK3beta in diabetic kidney disease | 000 | 4 | NIH | 6/26/2025 | $339,900 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AA029674 | Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies | 000 | 4 | NIH | 7/25/2025 | $416,030 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | F30AG079633 | AMPK localization, expression, and activity in Alzheimer's Disease | 001 | 4 | NIH | 8/19/2025 | -$43,355 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | F30AG079633 | AMPK localization, expression, and activity in Alzheimer's Disease | 000 | 4 | NIH | 8/7/2025 | $43,355 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R56MH139698 | Serotonin-mediated reorganization of the adolescent medial prefrontal cortex | 000 | 1 | NIH | 5/21/2025 | $545,759 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AG071332 | PPARG regulates osteocyte bioenergetics and function during aging | 000 | 5 | NIH | 6/3/2025 | $668,560 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614 | LUCAS | USA | R01CA258682 | Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | 000 | 4 | NIH | 9/15/2025 | $1,053,488 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK124098 | Gut-brain axis in Parkinson's disease | 000 | 5 | NIH | 8/26/2025 | $495,952 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS122534 | Pre and post-synaptic pathways underlying the stress response in the adrenal medulla | 000 | 10 | NIH | 4/10/2025 | $370,154 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01ES036248 | Developmental pyrethroid exposure in the prairie vole as a model of environmental risk for autism | 000 | 1 | NIH | 5/1/2025 | $605,550 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R00DA055064 | Investigating the long-term effects of prenatal circadian rhythm disruption on substance use-related disorders | 000 | 3 | NIH | 3/4/2025 | $248,996 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA286189 | Dormancy mimicking to inhibit prostate cancer metastasis progression and recurrence | 001 | 1 | NIH | 4/10/2025 | -$636,185 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA286189 | Dormancy mimicking to inhibit prostate cancer metastasis progression and recurrence | 000 | 1 | NIH | 1/24/2025 | $636,185 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R03CA286634 | TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer | 001 | 3 | NIH | 12/23/2024 | $78,125 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK134053 | Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | 000 | 3 | NIH | 2/20/2025 | $387,115 |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK134053 | Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | 001 | 3 | NIH | 6/11/2025 | $43,012 |
|
